EarliTec Diagnostics

EarliTec Diagnostics
EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.
About
What does EarliTec Diagnostics do?
EarliTec Diagnostics provides an FDA-cleared, eye-tracking technology system called EarliPoint® that aids qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children ages 16 months to 95 months. The system captures eye gaze data during video observation to analyze visual attention patterns, generating actionable insights on language, cognition, and social engagement to support early detection and track treatment progress. This technology is for clinician us…
What is EarliTec Diagnostics's revenue?
StartupHub estimates EarliTec Diagnostics's annual revenue at $6.8M (range $3.9M to $12.9M, 66% confidence), based on comparable companies in the sector.
What is EarliTec Diagnostics's valuation?
StartupHub estimates EarliTec Diagnostics's effective valuation at $165.6M (range $102.5M to $246.0M, 14% confidence), based on comparable companies in the sector.
How much funding has EarliTec Diagnostics raised?
EarliTec Diagnostics has raised a total of $41M in funding. The most recent round on record is Series B.
Where is EarliTec Diagnostics headquartered?
EarliTec Diagnostics is headquartered in Atlanta, United States.
When was EarliTec Diagnostics founded?
EarliTec Diagnostics was founded in 2019.
What industry does EarliTec Diagnostics operate in?
EarliTec Diagnostics operates in Healthcare, Autism, Diagnostics, HealthTech, MedTech, Digital Health.
How many employees does EarliTec Diagnostics have?
EarliTec Diagnostics has approximately 38 people on record.
No comments yet. Be the first to share your take.
